It has been shown that changes in the balance between BRCA1 FL [18,44] and the naturally occurring BRCA1 Δ11 isoforms may predispose to breast and ovarian cancer and promote resistance to PARPi [11,12]. Here, BRCA1 is linked to ovarian cancer.